Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory study of Niaspan on serum paraoxonase activity in hypercholesterolemia
2006-006889-42Phase 2Terminated
- Sponsor
- NOVA Medical School
- Start
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of niacin in hypercholesterolemia (2 arms), sponsored by NOVA Medical School. Primary endpoint: Change in serum paraoxonase activity. Started Feb 2007; status: terminated.
02
Drugs
niacin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on 2006-006889-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006889-42.